Skip to content
2000
image of Expression of TCEAL2 is a Novel Prognostic Biomarker and Potential Therapeutic Target in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma

Abstract

Background

Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) are major gynecological malignancies, causing significant cancer-related deaths in women. Current treatments yield poor outcomes, with a 5-year survival rate of only 17%. Identifying new biomarkers and therapeutic targets is crucial for improving prognosis and guiding personalized treatments.

Methods

We analyzed TCEAL2 expression using data from The Cancer Genome Atlas (TCGA) across various cancers, including CESC. We explored its correlation with clinical features, prognosis, immune infiltration, MSI, mRNAsi, and drug sensitivity. TCEAL2 expression was validated in GSE9750 datasets and CESC cell lines using qRT-PCR.

Results

TCEAL2 expression was significantly dysregulated in CESC. Elevated TCEAL2 levels correlated with poor clinical outcomes, including advanced pathological M stage ( = 0.009), initial treatment failure ( = 0.0098), and reduced overall survival (OS) ( = 0.013). TCEAL2 was an independent predictor of unfavorable OS ( = 0.032). It was associated with key pathways such as calcium signaling, oxidative phosphorylation, and Wnt signaling. TCEAL2 also correlated with immune cell infiltration, MSI, and mRNAsi. Notably, TCEAL2 levels inversely correlated with sensitivity to several drugs, including CAY10603 and SB-223133.

Discussion

The results suggest that TCEAL2 plays a significant role in CESC progression and its tumor microenvironment. Its correlation with immune infiltration and drug sensitivity highlights its potential as a prognostic biomarker and therapeutic target. Future studies should focus on elucidating the molecular mechanisms and validating their clinical utility.

Conclusion

TCEAL2 is a potential prognostic biomarker and therapeutic target in CESC. Further research is needed to explore its role and clinical applications.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673371499250714133701
2025-08-26
2025-11-04

  • From This Site

    /content/journals/cmc/10.2174/0109298673371499250714133701
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Aviel-Ronen S. Rubinek T. Zadok O. Vituri A. Avivi C. Wolf I. Barshack I. Klotho expression in cervical cancer: Differential expression in adenocarcinoma and squamous cell carcinoma. J. Clin. Pathol. 2016 69 1 53 57 10.1136/jclinpath‑2015‑202929 26209729
    [Google Scholar]
  2. Koh W.J. Abu-Rustum N.R. Bean S. Bradley K. Campos S.M. Cho K.R. Chon H.S. Chu C. Clark R. Cohn D. Crispens M.A. Damast S. Dorigo O. Eifel P.J. Fisher C.M. Frederick P. Gaffney D.K. Han E. Huh W.K. Lurain J.R. III Mariani A. Mutch D. Nagel C. Nekhlyudov L. Fader A.N. Remmenga S.W. Reynolds R.K. Tillmanns T. Ueda S. Wyse E. Yashar C.M. McMillian N.R. Scavone J.L. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 2019 17 1 64 84 10.6004/jnccn.2019.0001 30659131
    [Google Scholar]
  3. Berman T.A. Schiller J.T. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer 2017 123 12 2219 2229 10.1002/cncr.30588 28346680
    [Google Scholar]
  4. Tsu V. Jerónimo J. Saving the world’s women from cervical cancer. N. Engl. J. Med. 2016 374 26 2509 2511 10.1056/NEJMp1604113 27355529
    [Google Scholar]
  5. Xu Q. Wang J. Sun Y. Lin Y. Liu J. Zhuo Y. Huang Z. Huang S. Chen Y. Chen L. Ke M. Li L. Li Z. Pan J. Song Y. Liu R. Chen C. Efficacy and safety of sintilimab plus anlotinib for pd-l1–positive recurrent or metastatic cervical cancer: A multicenter, single-arm, prospective phase ii trial. J. Clin. Oncol. 2022 40 16 1795 1805 10.1200/JCO.21.02091 35192397
    [Google Scholar]
  6. Sun Y. Zhao J. Transcription Elongation Factor A. Transcription elongation factor A (SII)-Like (TCEAL) gene family member-TCEAL2: A novel prognostic marker in pan-cancer. Cancer Inform. 2022 21 11769351221126285 10.1177/11769351221126285 36199541
    [Google Scholar]
  7. Zhou Y. Zhang Y. Li W. Xu J. He X. Li X. Wang Y. TCEAL2 as a tumor suppressor in renal cell carcinoma is associated with the good prognosis of patients. Cancer Manag. Res. 2020 12 9589 9597 10.2147/CMAR.S271647 33061644
    [Google Scholar]
  8. Liang K. Xie R. Xie Z. Wan W. Fu X. Lai X. Li D. Miao H. MEF2C is a potential prognostic biomarker and is correlated with immune infiltrates in lung adenocarcinoma. Curr. Med. Chem. 2024 32 1 7 10.2174/0109298673317910241003101925 39428936
    [Google Scholar]
  9. Zhang J. Zhou Y. Li X. Wang S. Zhang P. Li D. Zhou Y. Expression profile and prognostic values of IRX family members in lung adenocarcinoma. Curr. Med. Chem. 2024 31 1 6 10.2174/0109298673320965240829065919 39248069
    [Google Scholar]
  10. Liu J. Lichtenberg T. Hoadley K.A. Poisson L.M. Lazar A.J. Cherniack A.D. Kovatich A.J. Benz C.C. Levine D.A. Lee A.V. Omberg L. Wolf D.M. Shriver C.D. Thorsson V. Hu H. Caesar-Johnson S.J. Demchok J.A. Felau I. Kasapi M. Ferguson M.L. Hutter C.M. Sofia H.J. Tarnuzzer R. Wang Z. Yang L. Zenklusen J.C. Zhang J.J. Chudamani S. Liu J. Lolla L. Naresh R. Pihl T. Sun Q. Wan Y. Wu Y. Cho J. DeFreitas T. Frazer S. Gehlenborg N. Getz G. Heiman D.I. Kim J. Lawrence M.S. Lin P. Meier S. Noble M.S. Saksena G. Voet D. Zhang H. Bernard B. Chambwe N. Dhankani V. Knijnenburg T. Kramer R. Leinonen K. Liu Y. Miller M. Reynolds S. Shmulevich I. Thorsson V. Zhang W. Akbani R. Broom B.M. Hegde A.M. Ju Z. Kanchi R.S. Korkut A. Li J. Liang H. Ling S. Liu W. Lu Y. Mills G.B. Ng K-S. Rao A. Ryan M. Wang J. Weinstein J.N. Zhang J. Abeshouse A. Armenia J. Chakravarty D. Chatila W.K. de Bruijn I. Gao J. Gross B.E. Heins Z.J. Kundra R. La K. Ladanyi M. Luna A. Nissan M.G. Ochoa A. Phillips S.M. Reznik E. Sanchez-Vega F. Sander C. Schultz N. Sheridan R. Sumer S.O. Sun Y. Taylor B.S. Wang J. Zhang H. Anur P. Peto M. Spellman P. Benz C. Stuart J.M. Wong C.K. Yau C. Hayes D.N. Parker J.S. Wilkerson M.D. Ally A. Balasundaram M. Bowlby R. Brooks D. Carlsen R. Chuah E. Dhalla N. Holt R. Jones S.J.M. Kasaian K. Lee D. Ma Y. Marra M.A. Mayo M. Moore R.A. Mungall A.J. Mungall K. Robertson A.G. Sadeghi S. Schein J.E. Sipahimalani P. Tam A. Thiessen N. Tse K. Wong T. Berger A.C. Beroukhim R. Cherniack A.D. Cibulskis C. Gabriel S.B. Gao G.F. Ha G. Meyerson M. Schumacher S.E. Shih J. Kucherlapati M.H. Kucherlapati R.S. Baylin S. Cope L. Danilova L. Bootwalla M.S. Lai P.H. Maglinte D.T. Van Den Berg D.J. Weisenberger D.J. Auman J.T. Balu S. Bodenheimer T. Fan C. Hoadley K.A. Hoyle A.P. Jefferys S.R. Jones C.D. Meng S. Mieczkowski P.A. Mose L.E. Perou A.H. Perou C.M. Roach J. Shi Y. Simons J.V. Skelly T. Soloway M.G. Tan D. Veluvolu U. Fan H. Hinoue T. Laird P.W. Shen H. Zhou W. Bellair M. Chang K. Covington K. Creighton C.J. Dinh H. Doddapaneni H.V. Donehower L.A. Drummond J. Gibbs R.A. Glenn R. Hale W. Han Y. Hu J. Korchina V. Lee S. Lewis L. Li W. Liu X. Morgan M. Morton D. Muzny D. Santibanez J. Sheth M. Shinbro E. Wang L. Wang M. Wheeler D.A. Xi L. Zhao F. Hess J. Appelbaum E.L. Bailey M. Cordes M.G. Ding L. Fronick C.C. Fulton L.A. Fulton R.S. Kandoth C. Mardis E.R. McLellan M.D. Miller C.A. Schmidt H.K. Wilson R.K. Crain D. Curley E. Gardner J. Lau K. Mallery D. Morris S. Paulauskis J. Penny R. Shelton C. Shelton T. Sherman M. Thompson E. Yena P. Bowen J. Gastier-Foster J.M. Gerken M. Leraas K.M. Lichtenberg T.M. Ramirez N.C. Wise L. Zmuda E. Corcoran N. Costello T. Hovens C. Carvalho A.L. de Carvalho A.C. Fregnani J.H. Longatto-Filho A. Reis R.M. Scapulatempo-Neto C. Silveira H.C.S. Vidal D.O. Burnette A. Eschbacher J. Hermes B. Noss A. Singh R. Anderson M.L. Castro P.D. Ittmann M. Huntsman D. Kohl B. Le X. Thorp R. Andry C. Duffy E.R. Lyadov V. Paklina O. Setdikova G. Shabunin A. Tavobilov M. McPherson C. Warnick R. Berkowitz R. Cramer D. Feltmate C. Horowitz N. Kibel A. Muto M. Raut C.P. Malykh A. Barnholtz-Sloan J.S. Barrett W. Devine K. Fulop J. Ostrom Q.T. Shimmel K. Wolinsky Y. Sloan A.E. De Rose A. Giuliante F. Goodman M. Karlan B.Y. Hagedorn C.H. Eckman J. Harr J. Myers J. Tucker K. Zach L.A. Deyarmin B. Hu H. Kvecher L. Larson C. Mural R.J. Somiari S. Vicha A. Zelinka T. Bennett J. Iacocca M. Rabeno B. Swanson P. Latour M. Lacombe L. Têtu B. Bergeron A. McGraw M. Staugaitis S.M. Chabot J. Hibshoosh H. Sepulveda A. Su T. Wang T. Potapova O. Voronina O. Desjardins L. Mariani O. Roman-Roman S. Sastre X. Stern M-H. Cheng F. Signoretti S. Berchuck A. Bigner D. Lipp E. Marks J. McCall S. McLendon R. Secord A. Sharp A. Behera M. Brat D.J. Chen A. Delman K. Force S. Khuri F. Magliocca K. Maithel S. Olson J.J. Owonikoko T. Pickens A. Ramalingam S. Shin D.M. Sica G. Van Meir E.G. Zhang H. Eijckenboom W. Gillis A. Korpershoek E. Looijenga L. Oosterhuis W. Stoop H. van Kessel K.E. Zwarthoff E.C. Calatozzolo C. Cuppini L. Cuzzubbo S. DiMeco F. Finocchiaro G. Mattei L. Perin A. Pollo B. Chen C. Houck J. Lohavanichbutr P. Hartmann A. Stoehr C. Stoehr R. Taubert H. Wach S. Wullich B. Kycler W. Murawa D. Wiznerowicz M. Chung K. Edenfield W.J. Martin J. Baudin E. Bubley G. Bueno R. De Rienzo A. Richards W.G. Kalkanis S. Mikkelsen T. Noushmehr H. Scarpace L. Girard N. Aymerich M. Campo E. Giné E. Guillermo A.L. Van Bang N. Hanh P.T. Phu B.D. Tang Y. Colman H. Evason K. Dottino P.R. Martignetti J.A. Gabra H. Juhl H. Akeredolu T. Stepa S. Hoon D. Ahn K. Kang K.J. Beuschlein F. Breggia A. Birrer M. Bell D. Borad M. Bryce A.H. Castle E. Chandan V. Cheville J. Copland J.A. Farnell M. Flotte T. Giama N. Ho T. Kendrick M. Kocher J-P. Kopp K. Moser C. Nagorney D. O’Brien D. O’Neill B.P. Patel T. Petersen G. Que F. Rivera M. Roberts L. Smallridge R. Smyrk T. Stanton M. Thompson R.H. Torbenson M. Yang J.D. Zhang L. Brimo F. Ajani J.A. Angulo Gonzalez A.M. Behrens C. Bondaruk J. Broaddus R. Czerniak B. Esmaeli B. Fujimoto J. Gershenwald J. Guo C. Lazar A.J. Logothetis C. Meric-Bernstam F. Moran C. Ramondetta L. Rice D. Sood A. Tamboli P. Thompson T. Troncoso P. Tsao A. Wistuba I. Carter C. Haydu L. Hersey P. Jakrot V. Kakavand H. Kefford R. Lee K. Long G. Mann G. Quinn M. Saw R. Scolyer R. Shannon K. Spillane A. Stretch J. Synott M. Thompson J. Wilmott J. Al-Ahmadie H. Chan T.A. Ghossein R. Gopalan A. Levine D.A. Reuter V. Singer S. Singh B. Tien N.V. Broudy T. Mirsaidi C. Nair P. Drwiega P. Miller J. Smith J. Zaren H. Park J-W. Hung N.P. Kebebew E. Linehan W.M. Metwalli A.R. Pacak K. Pinto P.A. Schiffman M. Schmidt L.S. Vocke C.D. Wentzensen N. Worrell R. Yang H. Moncrieff M. Goparaju C. Melamed J. Pass H. Botnariuc N. Caraman I. Cernat M. Chemencedji I. Clipca A. Doruc S. Gorincioi G. Mura S. Pirtac M. Stancul I. Tcaciuc D. Albert M. Alexopoulou I. Arnaout A. Bartlett J. Engel J. Gilbert S. Parfitt J. Sekhon H. Thomas G. Rassl D.M. Rintoul R.C. Bifulco C. Tamakawa R. Urba W. Hayward N. Timmers H. Antenucci A. Facciolo F. Grazi G. Marino M. Merola R. de Krijger R. Gimenez-Roqueplo A-P. Piché A. Chevalier S. McKercher G. Birsoy K. Barnett G. Brewer C. Farver C. Naska T. Pennell N.A. Raymond D. Schilero C. Smolenski K. Williams F. Morrison C. Borgia J.A. Liptay M.J. Pool M. Seder C.W. Junker K. Omberg L. Dinkin M. Manikhas G. Alvaro D. Bragazzi M.C. Cardinale V. Carpino G. Gaudio E. Chesla D. Cottingham S. Dubina M. Moiseenko F. Dhanasekaran R. Becker K-F. Janssen K-P. Slotta-Huspenina J. Abdel-Rahman M.H. Aziz D. Bell S. Cebulla C.M. Davis A. Duell R. Elder J.B. Hilty J. Kumar B. Lang J. Lehman N.L. Mandt R. Nguyen P. Pilarski R. Rai K. Schoenfield L. Senecal K. Wakely P. Hansen P. Lechan R. Powers J. Tischler A. Grizzle W.E. Sexton K.C. Kastl A. Henderson J. Porten S. Waldmann J. Fassnacht M. Asa S.L. Schadendorf D. Couce M. Graefen M. Huland H. Sauter G. Schlomm T. Simon R. Tennstedt P. Olabode O. Nelson M. Bathe O. Carroll P.R. Chan J.M. Disaia P. Glenn P. Kelley R.K. Landen C.N. Phillips J. Prados M. Simko J. Smith-McCune K. VandenBerg S. Roggin K. Fehrenbach A. Kendler A. Sifri S. Steele R. Jimeno A. Carey F. Forgie I. Mannelli M. Carney M. Hernandez B. Campos B. Herold-Mende C. Jungk C. Unterberg A. von Deimling A. Bossler A. Galbraith J. Jacobus L. Knudson M. Knutson T. Ma D. Milhem M. Sigmund R. Godwin A.K. Madan R. Rosenthal H.G. Adebamowo C. Adebamowo S.N. Boussioutas A. Beer D. Giordano T. Mes-Masson A-M. Saad F. Bocklage T. Landrum L. Mannel R. Moore K. Moxley K. Postier R. Walker J. Zuna R. Feldman M. Valdivieso F. Dhir R. Luketich J. Mora Pinero E.M. Quintero-Aguilo M. Carlotti C.G. Jr Dos Santos J.S. Kemp R. Sankarankuty A. Tirapelli D. Catto J. Agnew K. Swisher E. Creaney J. Robinson B. Shelley C.S. Godwin E.M. Kendall S. Shipman C. Bradford C. Carey T. Haddad A. Moyer J. Peterson L. Prince M. Rozek L. Wolf G. Bowman R. Fong K.M. Yang I. Korst R. Rathmell W.K. Fantacone-Campbell J.L. Hooke J.A. Kovatich A.J. Shriver C.D. DiPersio J. Drake B. Govindan R. Heath S. Ley T. Van Tine B. Westervelt P. Rubin M.A. Lee J.I. Aredes N.D. Mariamidze A. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 2018 173 2 400 416.e11 10.1016/j.cell.2018.02.052 29625055
    [Google Scholar]
  11. Lin Z. Huang W. Yi Y. Li D. Xie Z. Li Z. Ye M. LncRNA ADAMTS9-AS2 is a prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma. Int. J. Gen. Med. 2021 14 8541 8555 10.2147/IJGM.S340683 34849000
    [Google Scholar]
  12. Xia Y. Liu X. Ma B. Huang T. Xu D. Zhao C. Development and validation of a novel nomogram model for predicting the survival of patients with T2-4a, N0-x, M0 bladder cancer: A retrospective cohort study. Am. J. Clin. Exp. Urol. 2023 11 6 500 515 38148935
    [Google Scholar]
  13. Song Y. Yu H. RHBG Expression is correlated With ccRCC proliferation and immune infiltration. J. Food Nutr. Res. 2024 12 3 115 124 10.12691/jfnr‑12‑3‑2
    [Google Scholar]
  14. Liu J. Wang Y. Chen X. Chen X. Zhang M. ITGA5 is associated with prognosis marker and immunosuppression in head and neck squamous cell carcinoma. Diagn. Pathol. 2024 19 1 134 10.1186/s13000‑024‑01559‑1 39375732
    [Google Scholar]
  15. Chen T. Zhu C. Wang X. Pan Y. LncRNA ELF3-AS1 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Can. J. Gastroenterol. Hepatol. 2021 2021 1 12 10.1155/2021/8323487 34336727
    [Google Scholar]
  16. Wang H. Ding Y. He Y. Yu Z. Zhou Y. Gong A. Xu M. LncRNA UCA1 promotes pancreatic cancer cell migration by regulating mitochondrial dynamics via the MAPK pathway. Arch. Biochem. Biophys. 2023 748 109783 10.1016/j.abb.2023.109783 37816421
    [Google Scholar]
  17. Zhao Y. Song Y. Zhang Y. Ji M. Hou P. Sui F. Screening protective miRNAs and constructing novel lncRNAs/miRNAs/mRNAs networks and prognostic models for triple-negative breast cancer. Mol. Cell. Probes 2023 72 101940 10.1016/j.mcp.2023.101940 37871689
    [Google Scholar]
  18. Wang X. Yan G. Zhang X. Li D. Li G. LNX1-AS2 as a key prognostic and immunotherapy response biomarker for lung adenocarcinoma. Curr. Med. Chem. 2024 32 1 8 10.2174/0109298673321029241015153958 39484773
    [Google Scholar]
  19. Hänzelmann S. Castelo R. Guinney J. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics 2013 14 1 7 10.1186/1471‑2105‑14‑7 23323831
    [Google Scholar]
  20. Bindea G. Mlecnik B. Tosolini M. Kirilovsky A. Waldner M. Obenauf A.C. Angell H. Fredriksen T. Lafontaine L. Berger A. Bruneval P. Fridman W.H. Becker C. Pagès F. Speicher M.R. Trajanoski Z. Galon J. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 2013 39 4 782 795 10.1016/j.immuni.2013.10.003 24138885
    [Google Scholar]
  21. Ding X. Wan A. Qi X. Jiang K. Liu Z. Chen B. ZNF695, a potential prognostic biomarker, correlates with im mune infiltrates in cervical squamous cell carcinoma and endoce rvical adenocarcinoma: Bioinformatic analysis and experimental verification. Curr. Gene Ther. 2024 24 5 441 452 10.2174/0115665232285216240228071244 38441026
    [Google Scholar]
  22. Lu X. Jing L. Liu S. Wang H. Chen B. miR-149-3p is a potential prognosis biomarker and correlated with immune infiltrates in uterine corpus endometrial carcinoma. Int. J. Endocrinol. 2022 2022 1 15 10.1155/2022/5006123 35719192
    [Google Scholar]
  23. Yuan H. Jiang T. Zhang W.D. Yang Z. Luo S. Wang X. Zhu X. Qi S. Mahmmod Y.S. Zhang X.X. Yuan Z.G. Multiomics and bioinformatics identify differentially expressed effectors in the brain of Toxoplasma gondii infected masked palm civet. Front. Cell. Infect. Microbiol. 2023 13 1267629 10.3389/fcimb.2023.1267629 37818043
    [Google Scholar]
  24. Yoshihara K. Shahmoradgoli M. Martínez E. Vegesna R. Kim H. Torres-Garcia W. Treviño V. Shen H. Laird P.W. Levine D.A. Carter S.L. Getz G. Stemke-Hale K. Mills G.B. Verhaak R.G.W. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 2013 4 1 2612 10.1038/ncomms3612 24113773
    [Google Scholar]
  25. Ding H. Wang K. Chen S. Guo K.W. Qiu W. Validating the role of PTGIS gene in colorectal cancer by bioinformatics analysis and in vitro experiments. Sci. Rep. 2023 13 1 16496 10.1038/s41598‑023‑43289‑2 37779109
    [Google Scholar]
  26. Zhao W. Ou G. Lin W. Integrative analysis of neuregulin family members-related tumor microenvironment for predicting the prognosis in gliomas. Front. Immunol. 2021 12 682415 10.3389/fimmu.2021.682415 34054873
    [Google Scholar]
  27. Lian H. Han Y.P. Zhang Y.C. Zhao Y. Yan S. Li Q.F. Wang B.C. Wang J.J. Meng W. Yang J. Wang Q.H. Mao W.W. Ma J. Integrative analysis of gene expression and DNA methylation through one-class logistic regression machine learning identifies stemness features in medulloblastoma. Mol. Oncol. 2019 13 10 2227 2245 10.1002/1878‑0261.12557 31385424
    [Google Scholar]
  28. Huang Z. Hu X. Wei Y. Lai Y. Qi J. Pang J. Huang K. Li H. Cai P. ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification. PLoS One 2024 19 5 0303909 10.1371/journal.pone.0303909 38814950
    [Google Scholar]
  29. Chen B. Ding X. Wan A. Qi X. Lin X. Wang H. Mu W. Wang G. Zheng J. Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer. Sci. Rep. 2023 13 1 16244 10.1038/s41598‑023‑42171‑5 37758722
    [Google Scholar]
  30. Ye Y. Long F. Yue W. Wei Z. Yang J. Xie Y. Unveiling the enigmatic role of slc35f3 in lung adenocarcinoma. Clin. Respir. J. 2024 18 10 70023 10.1111/crj.70023 39414367
    [Google Scholar]
  31. Zhou B. Tie P. Li D. Lu Y. Liu Y. Unveiling the power of mitochondrial fission and fusion: A five-gene signature for personalized prognosis in gastric cancer. Curr. Med. Chem. 2024 31 1 5 10.2174/0109298673339515240930053412 39385415
    [Google Scholar]
  32. Chen X. Zhao X. Li D. Zha W. Identification of key genes and signaling pathways in entrectinibresistant non-small cell lung cancer using bioinformatic analysis and experimental verification. Curr. Med. Chem. 2024 31 10.2174/0109298673320448240801061941 39108112
    [Google Scholar]
  33. Sun C. Gao W. Liu J. Cheng H. Hao J. FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer. Respir. Res. 2020 21 1 210 10.1186/s12931‑020‑01477‑y 32778129
    [Google Scholar]
  34. Zhang Y. Zhou Y. Wei F. circABCB10 promotes malignant progression of gastric cancer cells by preventing the degradation of MYC. J. Oncol. 2021 2021 1 14 10.1155/2021/4625033 34950208
    [Google Scholar]
  35. Huang Y. Wu Q. Tan X. Metallothionein-like 5 expression is correlated with poor prognosis and promotes proliferation of cervical squamous cell carcinoma. Bioengineered 2022 13 3 6955 6965 10.1080/21655979.2022.2036901 35249447
    [Google Scholar]
  36. Dong Y. Wen W. Yuan T. Liu L. Li X. RILPL2 is associated with the progression and prognosis of cervical squamous cell carcinoma and endocervical adenocarcinoma. Am. J. Transl. Res. 2023 15 2 1072 1084 36915776
    [Google Scholar]
  37. Zhang Y. Wang H. Lu J. Lv Q. Yun B. Ge Z. Yan L. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma. Int. J. Immunopathol. Pharmacol. 2023 37 03946320231178131 10.1177/03946320231178131 37232164
    [Google Scholar]
  38. Zhang Y. Xu L. Li L. EGLN1: A biomarker of poor prognosis of cervical cancer and a target of treatment. Genet. Test. Mol. Biomarkers 2024 28 1 10 21 10.1089/gtmb.2023.0024 38294357
    [Google Scholar]
  39. Chen Y.F. Chen Y.T. Chiu W.T. Shen M.R. Remodeling of calcium signaling in tumor progression. J. Biomed. Sci. 2013 20 1 23 10.1186/1423‑0127‑20‑23 23594099
    [Google Scholar]
  40. Zhou Y. Yu S. Zhang W. NOD-like receptor signaling pathway in gastrointestinal inflammatory diseases and cancers. Int. J. Mol. Sci. 2023 24 19 14511 10.3390/ijms241914511 37833958
    [Google Scholar]
  41. Liu C. Zhang M. Yan X. Ni Y. Gong Y. Wang C. Zhang X. Wan L. Yang H. Ge C. Li Y. Zou W. Huang R. Li X. Sun B. Liu B. Yue J. Yu J. Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression. Sci. Adv. 2023 9 4 eadd8977 10.1126/sciadv.add8977 36706185
    [Google Scholar]
  42. Ashton T.M. McKenna W.G. Kunz-Schughart L.A. Higgins G.S. Oxidative phosphorylation as an emerging target in cancer therapy. Clin. Cancer Res. 2018 24 11 2482 2490 10.1158/1078‑0432.CCR‑17‑3070 29420223
    [Google Scholar]
  43. Jiang Y. Zhang H. Wang J. Chen J. Guo Z. Liu Y. Hua H. Exploiting RIG-I-like receptor pathway for cancer immunotherapy. J. Hematol. Oncol. 2023 16 1 8 10.1186/s13045‑023‑01405‑9 36755342
    [Google Scholar]
  44. Yang M. Wang M. Li X. Xie Y. Xia X. Tian J. Zhang K. Tang A. Wnt signaling in cervical cancer? J. Cancer 2018 9 7 1277 1286 10.7150/jca.22005 29675109
    [Google Scholar]
  45. Xia R. Xu M. Yang J. Ma X. The role of Hedgehog and Notch signaling pathway in cancer. Mol. Biomed. 2022 3 1 44 10.1186/s43556‑022‑00099‑8
    [Google Scholar]
  46. Kumari L. Yadav R. Kumar Y. Bhatia A. Role of tight junction proteins in shaping the immune milieu of malignancies. Expert Rev. Clin. Immunol. 2024 20 11 1305 1321 10.1080/1744666X.2024.2391915 39126381
    [Google Scholar]
  47. Munro M.J. Wickremesekera S.K. Peng L. Tan S.T. Itinteang T. Cancer stem cells in colorectal cancer: A review. J. Clin. Pathol. 2018 71 2 110 116 10.1136/jclinpath‑2017‑204739 28942428
    [Google Scholar]
  48. Wang L. Liu W. Liu J. Wang Y. Tai J. Yin X. Tan J. Identification of immune-related therapeutically relevant biomarkers in breast cancer and breast cancer stem cells by transcriptome-wide analysis: A clinical prospective study. Front. Oncol. 2021 10 554138 10.3389/fonc.2020.554138 33718103
    [Google Scholar]
  49. Rana D. Mandal B.M. Bhattacharyya S.N. Analogue calorimetric studies of blends of poly(vinyl ester)s and polyacrylates. Macromolecules 1996 29 5 1579 1583 10.1021/ma950954n
    [Google Scholar]
  50. Rana D. Bag K. Bhattacharyya S.N. Mandal B.M. Miscibility of poly(styrene-co-butyl acrylate) with poly(ethyl methacrylate): Existence of both UCST and LCST. J. Polym. Sci., B, Polym. Phys. 2000 38 3 369 375 10.1002/(SICI)1099‑0488(20000201)38:3<369::AID‑POLB3>3.0.CO;2‑W
    [Google Scholar]
  51. Rana D. Mandal B.M. Bhattacharyya S.N. Analogue calorimetry of polymer blends: Poly(styrene-co-acrylonitrile) and poly(phenyl acrylate) or poly(vinyl benzoate). Polymer 1996 37 12 2439 2443 10.1016/0032‑3861(96)85356‑0
    [Google Scholar]
  52. Rana D. Mandal B.M. Bhattacharyya S.N. Miscibility and phase diagrams of poly(phenyl acrylate) and poly(styrene-co-acrylonitrile) blends. Polymer 1993 34 7 1454 1459 10.1016/0032‑3861(93)90861‑4
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673371499250714133701
Loading
Expression of TCEAL2 is a Novel Prognostic Biomarker and Potential Therapeutic Target in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
Bentham Science Publishers ; https://doi.org/10.2174/0109298673371499250714133701
/content/journals/cmc/10.2174/0109298673371499250714133701
/content/journals/cmc/10.2174/0109298673371499250714133701
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: endocervical adenocarcinoma ; immune infiltration ; drug sensitivity ; Cervical squamous cell carcinoma ; prognosis ; TCEAL2 ; mRNAsi

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test